anmelden
FTSE All-Share
5.832,63
PKT
+38,13
PKT
+0,66
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.04.15 | GSK Hold | Jefferies & Company Inc. | |
| 13.04.15 | AstraZeneca buy | UBS AG | |
| 13.04.15 | Unilever Neutral | UBS AG | |
| 13.04.15 | HSBC Equal-Weight | Morgan Stanley | |
| 13.04.15 | Glencore Neutral | Citigroup Corp. | |
| 13.04.15 | Rio Tinto Neutral | Citigroup Corp. | |
| 13.04.15 | Unilever buy | Deutsche Bank AG | |
| 13.04.15 | Diageo buy | Deutsche Bank AG | |
| 13.04.15 | Glencore Hold | Deutsche Bank AG | |
| 13.04.15 | Unilever neutral | Barclays Capital | |
| 13.04.15 | Unilever Equal weight | Barclays Capital | |
| 13.04.15 | Barclays buy | Société Générale Group S.A. (SG) | |
| 10.04.15 | Glencore Equal-Weight | Morgan Stanley | |
| 10.04.15 | Vodafone Group overweight | Barclays Capital | |
| 09.04.15 | Shell (ex Royal Dutch Shell) Hold | Deutsche Bank AG | |
| 09.04.15 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 09.04.15 | Rio Tinto Neutral | Credit Suisse Group | |
| 09.04.15 | Glencore Outperform | Credit Suisse Group | |
| 09.04.15 | Unilever Reduce | Nomura | |
| 09.04.15 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 08.04.15 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 08.04.15 | Glencore Underweight | JP Morgan Chase & Co. | |
| 08.04.15 | AstraZeneca verkaufen | Morgan Stanley | |
| 02.04.15 | Shell (ex Royal Dutch Shell) Equal-Weight | Morgan Stanley | |
| 02.04.15 | BT Group Neutral | UBS AG | |
| 02.04.15 | HSBC buy | Goldman Sachs Group Inc. | |
| 01.04.15 | Lloyds Banking Group Hold | Jefferies & Company Inc. | |
| 01.04.15 | National Grid Neutral | Citigroup Corp. | |
| 01.04.15 | Lloyds Banking Group overweight | Morgan Stanley | |
| 01.04.15 | HSBC Underweight | Morgan Stanley | |
| 01.04.15 | Diageo Neutral | Nomura | |
| 01.04.15 | Barclays overweight | Morgan Stanley | |
| 01.04.15 | AstraZeneca Underweight | Barclays Capital | |
| 01.04.15 | GSK overweight | Barclays Capital | |
| 01.04.15 | Standard Chartered Underweight | Morgan Stanley | |
| 01.04.15 | Vodafone Group Reduce | Nomura | |
| 01.04.15 | Glencore Underweight | JP Morgan Chase & Co. | |
| 01.04.15 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 30.03.15 | BT Group buy | HSBC | |
| 30.03.15 | Barclays overweight | JP Morgan Chase & Co. |
